D.A. Wallach Explains Why Biotech VC Is So Different
Most people think of venture capital as funding software startups or, these days, some new AI tool. But VC also plays a major role in developing new medicines and treatments. That’s the world of D.A. Wallach — though he didn’t start there. Before becoming a biotech investor, Wallach was the lead singer of the indie…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Odd Lots
See all episodes →Similar episodes from other shows
More like Odd Lots →
E157: DA Wallach: Spotting Genius in Elon & Zuck's Early Days
Can America Win The AI Biotech Race Against China? | Lada Nuzhna & Elliot Hershberg
59%Felicis founder Aydin Senkut: why moats are dead and alive
20VC: Why Fund Returners Are Not Enough Anymore | Why Sequoia Had the Best Strategy at the Worst Time | What it Takes to Be Good at Series A and B Today | Benchmark Leads Manus Round: Should US Funds Invest in Chinese AI
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.